{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:02:49Z","timestamp":1790694169537,"version":"4.1.0"},"reference-count":46,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,12,1]]},"abstract":"<jats:p>Scorpion venom, containing highly toxic, small polypeptides that diffuse rapidly within the patient, causes serious medical problems. Nanobodies, single-domain antigen-binding fragments derived from dromedary heavy-chain antibodies, have a size that closely matches that of scorpion toxins. Therefore these nanobodies might be developed into potent immunotherapeutics to treat scorpion envenoming. Multiple nanobodies of sub-nanomolar affinity to AahII, the most toxic polypeptide within the Androctonus australis hector venom, were isolated from a dromedary immunized with AahII. These nanobodies neutralize the lethal effect of AahII to various extents without clear correlation with the kinetic rate constants kon or koff, or the equilibrium dissociation constant, KD. One particular nanobody, referred to as NbAahII10, which targets a unique epitope on AahII, neutralizes 7 LD50 of this toxin in mice, corresponding to a neutralizing capacity of approx. 37000 LD50 of AahII\/mg of nanobody. Such high neutralizing potency has never been reached before by any other monoclonal antibody fragment.<\/jats:p>","DOI":"10.1042\/bj20090697","type":"journal-article","created":{"date-parts":[[2009,9,7]],"date-time":"2009-09-07T14:34:32Z","timestamp":1252334072000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom"],"prefix":"10.1042","volume":"424","author":[{"given":"Rahma\u00a0Ben","family":"Abderrazek","sequence":"first","affiliation":[{"name":"Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam","family":"Hmila","sequence":"additional","affiliation":[{"name":"Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Vincke","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"},{"name":"Department of Cellular and Molecular Interactions, Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Benlasfar","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des services animaliers-Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Pellis","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"},{"name":"Department of Cellular and Molecular Interactions, Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafedh","family":"Dabbek","sequence":"additional","affiliation":[{"name":"Centre r\u00e9gional de production animali\u00e8re de K\u00e9bili, 4200 K\u00e9bili, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Saerens","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"},{"name":"Department of Cellular and Molecular Interactions, Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El\u00a0Ayeb","sequence":"additional","affiliation":[{"name":"Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Muyldermans","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"},{"name":"Department of Cellular and Molecular Interactions, Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balkiss","family":"Bouhaouala-Zahar","sequence":"additional","affiliation":[{"name":"Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia"},{"name":"Facult\u00e9 de M\u00e9decine de Tunis, Universit\u00e9 de Tunis-El Manar, Tunis Romana 1068, Tunis BP94, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2009,11,11]]},"reference":[{"key":"2021112217234816800_B1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0041-0101(94)90383-2","article-title":"Scorpionism and serotherapy in Mexico","volume":"32","author":"Dehesa-Davila","year":"1994","journal-title":"Toxicon"},{"key":"2021112217234816800_B2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0041-0101(82)90240-9","article-title":"Epidemiology and clinical characteristics of scorpion envenomation in Tunisia","volume":"20","author":"Goyffon","year":"1982","journal-title":"Toxicon"},{"key":"2021112217234816800_B3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.toxicon.2008.09.004","article-title":"Epidemiological, clinical characteristics and outcome of severe scorpion envenomation in South Tunisia: multivariate analysis of 951 cases","volume":"52","author":"Bouaziz","year":"2008","journal-title":"Toxicon"},{"key":"2021112217234816800_B4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0006-291X(80)80082-9","article-title":"Two types of scorpion neurotoxin characterized by their binding to two separate receptor sites on rat brain synaptosomes","volume":"95","author":"Jover","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112217234816800_B5","first-page":"683","article-title":"Scorpions neurotoxins. Effects and Mechanisms","volume-title":"Handbook of Neurotoxicity","author":"Martin-Eauclaire","year":"1995"},{"key":"2021112217234816800_B6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.toxicon.2004.02.021","article-title":"Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom","volume":"43","author":"Devaux","year":"2004","journal-title":"Toxicon"},{"key":"2021112217234816800_B7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1432-1033.1970.tb01111.x","article-title":"Purification of animal neurotoxins. Isolation and characterization of eleven neurotoxins from the venom of the scorpion Androctonus australis hector, Buthus occitanus tunetanus and Leiurus quinquestriatus quinquestriatus","volume":"16","author":"Miranda","year":"1970","journal-title":"Eur. J. Biochem."},{"key":"2021112217234816800_B8","first-page":"325","article-title":"Scorpion toxins: chemistry and mode of action","volume":"3","author":"Rochat","year":"1979","journal-title":"Adv. Cytopharmacol."},{"key":"2021112217234816800_B9","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1073\/pnas.85.20.7443","article-title":"Orthorhombic crystals and three-dimensional structure of the potent toxin II from the scorpion","volume":"85","author":"Fontecilla-Camps","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112217234816800_B10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jmbi.1994.1270","article-title":"Crystal structure of toxinII from the scorpion Androctonus australis hector refined at 1.3 \u00c5 resolution","volume":"238","author":"Housset","year":"1994","journal-title":"J. Mol. Biol."},{"key":"2021112217234816800_B11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0161-5890(83)90047-0","article-title":"Immunochemistry of scorpion \u03b1-neurotoxins. Determination of the antigenic site number and isolation of a highly enriched antibody specific to a single antigenic site of toxin II of Androctonus australis hector","volume":"20","author":"El\u00a0Ayeb","year":"1983","journal-title":"Mol. Immunol."},{"key":"2021112217234816800_B12","first-page":"3371","article-title":"Use of antibodies specific to defined regions of scorpion \u03b1-toxin to study its interaction with its receptor sites on the sodium channel","volume":"139","author":"El\u00a0Ayeb","year":"1986","journal-title":"Biochemistry"},{"key":"2021112217234816800_B13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0161-5890(89)90001-1","article-title":"The antigenic structure of a scorpion toxin","volume":"26","author":"Granier","year":"1989","journal-title":"Mol. Immunol."},{"key":"2021112217234816800_B14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0041-0101(97)00160-8","article-title":"Venoms, antivenoms and immunotherapy","volume":"36","author":"Chippaux","year":"1998","journal-title":"Toxicon"},{"key":"2021112217234816800_B15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0041-008X(96)80033-0","article-title":"Immunoreactivity and pharmacokinetic of horse anti-scorpion venom F(ab\u2032)2 scorpion venom interactions","volume":"141","author":"Pepin-Cavotta","year":"1996","journal-title":"Toxicol. App. Pharmacol."},{"key":"2021112217234816800_B16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0041-0101(94)90384-0","article-title":"The treatment of the scorpion envenoming syndrome: the Saudi experience with serotherapy","volume":"32","author":"Ismail","year":"1994","journal-title":"Toxicon"},{"key":"2021112217234816800_B17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(98)12083-4","article-title":"Serotherapy in scorpion envenomation: a randomised controlled trial","volume":"354","author":"Abroug","year":"1999","journal-title":"Lancet"},{"key":"2021112217234816800_B18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0041-0101(98)00141-X","article-title":"Immunotherapy for scorpion envenoming in Brazil","volume":"36","author":"Rezende","year":"1998","journal-title":"Toxicon"},{"key":"2021112217234816800_B19","first-page":"14","article-title":"Utility of scorpion antivenin vs prazosin in the management of severe Mesobuthus tamulus envenoming at rural settings","volume":"55","author":"Bawaskar","year":"2007","journal-title":"J. Assoc. Physicians India"},{"key":"2021112217234816800_B20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-3476(05)83196-8","article-title":"Scorpion envenomation and antivenom therapy","volume":"124","author":"Sofer","year":"1994","journal-title":"J. Pediatr."},{"key":"2021112217234816800_B21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4049\/jimmunol.141.1.214","article-title":"Monoclonal antobodies to scorpion toxins characterization and molecular mechanisms of neutralization","volume":"141","author":"Bahraoui","year":"1988","journal-title":"J. Immunol."},{"key":"2021112217234816800_B22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(98)01647-0","article-title":"A recombinant single chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector","volume":"452","author":"Mousli","year":"1999","journal-title":"FEBS Lett."},{"key":"2021112217234816800_B23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1432-1327.2001.01923.x","article-title":"Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector","volume":"268","author":"Devaux","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"2021112217234816800_B24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00018-006-6401-3","article-title":"Using a recombinant bispecific antibody to block Na+-channel toxins protects against experimental scorpion envenoming","volume":"64","author":"Juste","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"2021112217234816800_B25","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/j.1742-4658.2005.04687.x","article-title":"A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom","volume":"272","author":"Ria\u00f1o-Umbarila","year":"2005","journal-title":"FEBS J."},{"key":"2021112217234816800_B26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0065-2776(01)79006-2","article-title":"Functional heavy-chain antibodies in Camelidae","volume":"79","author":"Nguyen","year":"2001","journal-title":"Adv. Immunol."},{"key":"2021112217234816800_B27","first-page":"1256","article-title":"Efficient cancer therapy with a nanobody-based conjugate","volume":"279","author":"Cortez-Retamozo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112217234816800_B28","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1021\/ac051092j","article-title":"Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing","volume":"77","author":"Saerens","year":"2005","journal-title":"Anal. Chem."},{"key":"2021112217234816800_B29","first-page":"914","article-title":"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor","volume":"22","author":"Baral","year":"2006","journal-title":"Med. Sci."},{"key":"2021112217234816800_B30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","article-title":"Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains","volume":"7","author":"Muyldermans","year":"1994","journal-title":"Prot. Eng."},{"key":"2021112217234816800_B31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.toxicon.2003.10.021","article-title":"Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins","volume":"42","author":"Meddeb-Mouelhi","year":"2003","journal-title":"Toxicon"},{"key":"2021112217234816800_B32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0014-5793(97)01062-4","article-title":"Selection and identification of single-domain antibody fragments from camel heavy-chain antibodies","volume":"414","author":"Arbabi-Ghahroudi","year":"1997","journal-title":"FEBS Lett."},{"key":"2021112217234816800_B33","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/AAC.45.10.2807-2812.2001","article-title":"\u03b2-Lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae","volume":"45","author":"Conrath","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021112217234816800_B34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1432-1033.1996.0653w.x","article-title":"A recombinant insect-specific \u03b1-toxin of Buthus occitanus tunetanus scorpion confers protection against homologous mammal toxins","volume":"238","author":"Bouhaouala-Zahar","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"2021112217234816800_B35","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.molimm.2008.04.011","article-title":"VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI\u2032","volume":"45","author":"Hmila","year":"2008","journal-title":"Mol. Immunol."},{"key":"2021112217234816800_B36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0145-305X(02)00039-3","article-title":"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains","volume":"27","author":"Lefranc","year":"2003","journal-title":"Dev. Comp. Immunol."},{"key":"2021112217234816800_B37","doi-asserted-by":"crossref","first-page":"14114","DOI":"10.1074\/jbc.M413011200","article-title":"Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires","volume":"280","author":"De\u00a0Genst","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112217234816800_B38","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"De\u00a0Genst","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112217234816800_B39","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1021\/bi00541a016","article-title":"Neutralizing monoclonal antibody specific for Naja nigrcollis toxin \u03b1 preparation, characterization and localization of the antigenic binding site","volume":"21","author":"Boulain","year":"1982","journal-title":"Biochemistry"},{"key":"2021112217234816800_B40","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/0161-5890(86)90018-0","article-title":"Two neutralizing monoclonal antibodies specific for Naja nigricollis cardiotoxin: preparation, characterization and localisation of the epitopes","volume":"23","author":"Grognet","year":"1986","journal-title":"Mol. Immunol."},{"key":"2021112217234816800_B41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jmb.2004.12.060","article-title":"Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2","volume":"346","author":"Juarez-Gonzalez","year":"2005","journal-title":"J. Mol. Biol."},{"key":"2021112217234816800_B42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.molimm.2006.05.009","article-title":"The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies","volume":"44","author":"Quintero-Hern\u00e1ndez","year":"2007","journal-title":"Mol. Immunol."},{"key":"2021112217234816800_B43","first-page":"277","article-title":"Single domain camel antibodies: current status","volume":"74","author":"Muyldermans","year":"2001","journal-title":"J. Biotechnol."},{"key":"2021112217234816800_B44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0141-0229(01)00497-5","article-title":"Large-scale production of VHH antibody fragments by Saccharomyces cerevisiae","volume":"30","author":"Thomassen","year":"2002","journal-title":"Enzyme Microb. Technol."},{"key":"2021112217234816800_B45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0168-1656(99)00228-X","article-title":"Isolation of antigen specific Llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae","volume":"78","author":"Frenken","year":"2000","journal-title":"J. Biotechnol."},{"key":"2021112217234816800_B46","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","article-title":"General strategy to humanize a camel single domain antibody and identification of a universal humanized nanobody scaffold","volume":"284","author":"Vincke","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/424\/2\/263\/660199\/bj4240263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/424\/2\/263\/660199\/bj4240263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T09:22:42Z","timestamp":1710580962000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/424\/2\/263\/79912\/Identification-of-potent-nanobodies-to-neutralize"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,11]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20090697","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,11]]}}}